Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals.
about
SPARC ameliorates ovarian cancer-associated inflammation.Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy.Progress in the management of primary and recurrent ovarian carcinomatosis with peritonectomy procedure and HIPEC in a high volume centre.Imaging of 186Re-liposome therapy in ovarian cancer xenograft model of peritoneal carcinomatosis.Postoperative time course and utility of inflammatory markers in patients with ovarian peritoneal carcinomatosis treated with neoadjuvant chemotherapy, cytoreductive surgery, and HIPEC.
P2860
Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Treatment of peritoneal carcin ...... ture directions and proposals.
@en
type
label
Treatment of peritoneal carcin ...... ture directions and proposals.
@en
prefLabel
Treatment of peritoneal carcin ...... ture directions and proposals.
@en
P2093
P2860
P1476
Treatment of peritoneal carcin ...... ture directions and proposals.
@en
P2093
Díaz-Iglesias C
González-Bayón L
González-Moreno S
Gómez-Portilla A
P2860
P2888
P304
P356
10.1007/S12094-007-0118-0
P577
2007-10-01T00:00:00Z